322 related articles for article (PubMed ID: 30662368)
1. Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study.
Pérez-Sánchez G; Becerril-Villanueva E; Arreola R; Martínez-Levy G; Hernández-Gutiérrez ME; Velasco-Velásquez MA; Alvarez-Herrera S; Cruz-Fuentes C; Palacios L; de la Peña F; Pavón L
Mediators Inflamm; 2018; 2018():4074051. PubMed ID: 30662368
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.
Song C; Halbreich U; Han C; Leonard BE; Luo H
Pharmacopsychiatry; 2009 Sep; 42(5):182-8. PubMed ID: 19724980
[TBL] [Abstract][Full Text] [Related]
3. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
[TBL] [Abstract][Full Text] [Related]
4. Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder.
Chen CY; Yeh YW; Kuo SC; Liang CS; Ho PS; Huang CC; Yen CH; Shyu JF; Lu RB; Huang SY
Psychoneuroendocrinology; 2018 Jan; 87():108-118. PubMed ID: 29055264
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine.
Becerril-Villanueva E; Pérez-Sánchez G; Alvarez-Herrera S; Girón-Pérez MI; Arreola R; Cruz-Fuentes C; Palacios L; de la Peña FR; Pavón L
Mediators Inflamm; 2019; 2019():9130868. PubMed ID: 31827384
[TBL] [Abstract][Full Text] [Related]
7. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder.
Jazayeri S; Keshavarz SA; Tehrani-Doost M; Djalali M; Hosseini M; Amini H; Chamari M; Djazayery A
Psychiatry Res; 2010 Jun; 178(1):112-5. PubMed ID: 20466437
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder.
Guo J; Zhang T; Chen W; Tan J; Li X; Zheng A; Fu Y; Qiu T
BMC Psychiatry; 2024 Apr; 24(1):285. PubMed ID: 38627683
[TBL] [Abstract][Full Text] [Related]
9. Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression.
Schmidt FM; Schröder T; Kirkby KC; Sander C; Suslow T; Holdt LM; Teupser D; Hegerl U; Himmerich H
Psychiatry Res; 2016 May; 239():85-91. PubMed ID: 27137966
[TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
[TBL] [Abstract][Full Text] [Related]
11. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
Dahl J; Ormstad H; Aass HC; Malt UF; Bendz LT; Sandvik L; Brundin L; Andreassen OA
Psychoneuroendocrinology; 2014 Jul; 45():77-86. PubMed ID: 24845179
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine modulates the pro-inflammatory process of IL-6, IL-1β and TNF-α levels in individuals with depression: a systematic review and meta-analysis.
García-García ML; Tovilla-Zárate CA; Villar-Soto M; Juárez-Rojop IE; González-Castro TB; Genis-Mendoza AD; Ramos-Méndez MÁ; López-Nárvaez ML; Saucedo-Osti AS; Ruiz-Quiñones JA; Martinez-Magaña JJ
Psychiatry Res; 2022 Jan; 307():114317. PubMed ID: 34864233
[TBL] [Abstract][Full Text] [Related]
13. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
Lee H; Song M; Lee J; Kim JB; Lee MS
J Affect Disord; 2020 Apr; 266():57-62. PubMed ID: 32056928
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory modulation of fluoxetine use in patients with depression: A systematic review and meta-analysis.
Almeida IB; Gomes IA; Shanmugam S; de Moura TR; Magalhães LS; de Aquino LAG; de Souza Araújo AA; Oliveira PD; Santos MRV
Cytokine; 2020 Jul; 131():155100. PubMed ID: 32315957
[TBL] [Abstract][Full Text] [Related]
15. The cytokine profile of women with severe anxiety and depression during pregnancy.
Leff Gelman P; Mancilla-Herrera I; Flores-Ramos M; Saravia Takashima MF; Cruz Coronel FM; Cruz Fuentes C; Pérez Molina A; Hernández-Ruiz J; Silva-Aguilera FS; Farfan-Labonne B; Chinchilla-Ochoa D; Garza Morales S; Camacho-Arroyo I
BMC Psychiatry; 2019 Apr; 19(1):104. PubMed ID: 30943938
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.
Lee KM; Kim YK
Int Immunopharmacol; 2006 Aug; 6(8):1298-304. PubMed ID: 16782542
[TBL] [Abstract][Full Text] [Related]
17. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
[TBL] [Abstract][Full Text] [Related]
18. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
Zou W; Feng R; Yang Y
PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
[TBL] [Abstract][Full Text] [Related]
19. Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.
Hernández ME; Mendieta D; Martínez-Fong D; Loría F; Moreno J; Estrada I; Bojalil R; Pavón L
Eur Neuropsychopharmacol; 2008 Dec; 18(12):917-24. PubMed ID: 18805677
[TBL] [Abstract][Full Text] [Related]
20. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
